Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

CCR2 mediates the adverse effects of LPS in the pregnant mouse.

Hua R, Edey LF, O'Dea KP, Howe L, Herbert BR, Cheng W, Zheng X, MacIntyre DA, Bennett PR, Takata M, Johnson MR.

Biol Reprod. 2019 Oct 10. pii: ioz188. doi: 10.1093/biolre/ioz188. [Epub ahead of print]

PMID:
31599921
2.

The association between vaginal bacterial composition and miscarriage: a nested case-control study.

Al-Memar M, Bobdiwala S, Fourie H, Manino R, Lee YS, Smith A, Marchesi JR, Timmerman D, Bourne T, Bennett PR, MacIntyre DA.

BJOG. 2019 Oct 1. doi: 10.1111/1471-0528.15972. [Epub ahead of print]

PMID:
31573753
3.

Oligonucleotide-templated lateral flow assays for amplification-free sensing of circulating microRNAs.

Pavagada S, Channon RB, Chang JYH, Kim SH, MacIntyre D, Bennett PR, Terzidou V, Ladame S.

Chem Commun (Camb). 2019 Oct 15;55(83):12451-12454. doi: 10.1039/c9cc05607f.

PMID:
31556888
4.

Reducing the impact of preterm birth: Preterm birth commissioning in the United Kingdom.

Story L, Simpson NAB, David AL, Alfirevic Z Z, Bennett PR, Jolly M, Shennan AH; UK Preterm Clinical Network.

Eur J Obstet Gynecol Reprod Biol X. 2019 Apr 21;3:100018. doi: 10.1016/j.eurox.2019.100018. eCollection 2019 Jul. Review.

5.

The vaginal microbiome in uterine transplantation.

Jones BP, Saso S, L'Heveder A, Bracewell-Milnes T, Thum MY, Diaz-Garcia C, MacIntyre DA, Quiroga I, Ghaem-Maghami S, Testa G, Johannesson L, Bennett PR, Yazbek J, Smith JR.

BJOG. 2019 Aug 8. doi: 10.1111/1471-0528.15881. [Epub ahead of print] Review.

PMID:
31397072
6.

Cervical length and quantitative fetal fibronectin in the prediction of spontaneous preterm birth in asymptomatic women with congenital uterine anomaly.

Ridout AE, Ibeto LA, Ross GN, Cook JR, Sykes L, David AL, Seed PT, Tribe RM, Bennett PR, Terzidou V, Shennan AH, Chandiramani M; collaborators, Brown RG, Chatfield S, Sadeh D.

Am J Obstet Gynecol. 2019 Oct;221(4):341.e1-341.e9. doi: 10.1016/j.ajog.2019.05.032. Epub 2019 May 24.

PMID:
31132343
7.

First Trimester Circulating MicroRNA Biomarkers Predictive of Subsequent Preterm Delivery and Cervical Shortening.

Cook J, Bennett PR, Kim SH, Teoh TG, Sykes L, Kindinger LM, Garrett A, Binkhamis R, MacIntyre DA, Terzidou V.

Sci Rep. 2019 Apr 10;9(1):5861. doi: 10.1038/s41598-019-42166-1.

8.

Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F-induced Contractions and Inflammatory Responses in Human Myometrium.

Kim SH, Riaposova L, Ahmed H, Pohl O, Chollet A, Gotteland JP, Hanyaloglu A, Bennett PR, Terzidou V.

Sci Rep. 2019 Apr 8;9(1):5792. doi: 10.1038/s41598-019-42181-2.

9.

Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage.

Brown RG, Chan D, Terzidou V, Lee YS, Smith A, Marchesi JR, MacIntyre DA, Bennett PR.

BJOG. 2019 Jun;126(7):916-925. doi: 10.1111/1471-0528.15600. Epub 2019 Mar 10.

10.

Establishment of vaginal microbiota composition in early pregnancy and its association with subsequent preterm prelabor rupture of the fetal membranes.

Brown RG, Al-Memar M, Marchesi JR, Lee YS, Smith A, Chan D, Lewis H, Kindinger L, Terzidou V, Bourne T, Bennett PR, MacIntyre DA.

Transl Res. 2019 May;207:30-43. doi: 10.1016/j.trsl.2018.12.005. Epub 2018 Dec 27.

11.

Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2-a study protocol.

Norman JE, Norrie J, Maclennan G, Cooper D, Whyte S, Cunningham Burley S, Smith JBE, Shennan A, Robson SC, Thornton S, Kilby MD, Marlow N, Stock SJ, Bennett PR, Denton J.

BMJ Open. 2018 Dec 6;8(12):e026430. doi: 10.1136/bmjopen-2018-026430.

12.

Efficacy of progesterone for prevention of preterm birth.

Sykes L, Bennett PR.

Best Pract Res Clin Obstet Gynaecol. 2018 Oct;52:126-136. doi: 10.1016/j.bpobgyn.2018.08.006. Epub 2018 Sep 8. Review.

13.

Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function.

Tay J, Masini G, McEniery CM, Giussani DA, Shaw CJ, Wilkinson IB, Bennett PR, Lees CC.

Am J Obstet Gynecol. 2019 Jan;220(1):96.e1-96.e8. doi: 10.1016/j.ajog.2018.09.017. Epub 2018 Sep 19.

14.

Association Between Prepregnancy Cardiovascular Function and Subsequent Preeclampsia or Fetal Growth Restriction.

Foo FL, Mahendru AA, Masini G, Fraser A, Cacciatore S, MacIntyre DA, McEniery CM, Wilkinson IB, Bennett PR, Lees CC.

Hypertension. 2018 Aug;72(2):442-450. doi: 10.1161/HYPERTENSIONAHA.118.11092. Epub 2018 Jul 2.

15.

Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM).

Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, Robson SC, McConnachie A, Petrou S, Sebire NJ, Lavender T, Whyte S, Norrie J.

Health Technol Assess. 2018 Jun;22(35):1-304. doi: 10.3310/hta22350.

16.

OBE022, an Oral and Selective Prostaglandin F2α Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor.

Pohl O, Chollet A, Kim SH, Riaposova L, Spézia F, Gervais F, Guillaume P, Lluel P, Méen M, Lemaux F, Terzidou V, Bennett PR, Gotteland JP.

J Pharmacol Exp Ther. 2018 Aug;366(2):349-364. doi: 10.1124/jpet.118.247668. Epub 2018 May 18.

PMID:
29777040
17.

Assessment of microbiota:host interactions at the vaginal mucosa interface.

Pruski P, Lewis HV, Lee YS, Marchesi JR, Bennett PR, Takats Z, MacIntyre DA.

Methods. 2018 Oct 1;149:74-84. doi: 10.1016/j.ymeth.2018.04.022. Epub 2018 Apr 27. Review.

18.

Early and late preeclampsia are characterized by high cardiac output, but in the presence of fetal growth restriction, cardiac output is low: insights from a prospective study.

Tay J, Foo L, Masini G, Bennett PR, McEniery CM, Wilkinson IB, Lees CC.

Am J Obstet Gynecol. 2018 May;218(5):517.e1-517.e12. doi: 10.1016/j.ajog.2018.02.007. Epub 2018 Feb 21.

19.

Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin.

Brown RG, Marchesi JR, Lee YS, Smith A, Lehne B, Kindinger LM, Terzidou V, Holmes E, Nicholson JK, Bennett PR, MacIntyre DA.

BMC Med. 2018 Jan 24;16(1):9. doi: 10.1186/s12916-017-0999-x.

20.

Urinary Metabolic Phenotyping of Women with Lower Urinary Tract Symptoms.

Bray R, Cacciatore S, Jiménez B, Cartwright R, Digesu A, Fernando R, Holmes E, Nicholson JK, Bennett PR, MacIntyre DA, Khullar V.

J Proteome Res. 2017 Nov 3;16(11):4208-4216. doi: 10.1021/acs.jproteome.7b00568. Epub 2017 Oct 4.

21.

Comparison of vaginal microbiota sampling techniques: cytobrush versus swab.

Mitra A, MacIntyre DA, Mahajan V, Lee YS, Smith A, Marchesi JR, Lyons D, Bennett PR, Kyrgiou M.

Sci Rep. 2017 Aug 29;7(1):9802. doi: 10.1038/s41598-017-09844-4.

22.

Cerclage position, cervical length and preterm delivery in women undergoing ultrasound indicated cervical cerclage: A retrospective cohort study.

Cook JR, Chatfield S, Chandiramani M, Kindinger L, Cacciatore S, Sykes L, Teoh T, Shennan A, Terzidou V, Bennett PR.

PLoS One. 2017 Jun 1;12(6):e0178072. doi: 10.1371/journal.pone.0178072. eCollection 2017.

23.

Preconception and early pregnancy maternal haemodynamic changes in healthy women in relation to pregnancy viability.

Foo FL, Collins A, McEniery CM, Bennett PR, Wilkinson IB, Lees CC.

Hum Reprod. 2017 May 1;32(5):985-992. doi: 10.1093/humrep/dex050.

24.

Medical Swab Analysis Using Desorption Electrospray Ionization Mass Spectrometry: A Noninvasive Approach for Mucosal Diagnostics.

Pruski P, MacIntyre DA, Lewis HV, Inglese P, Correia GD, Hansel TT, Bennett PR, Holmes E, Takats Z.

Anal Chem. 2017 Feb 7;89(3):1540-1550. doi: 10.1021/acs.analchem.6b03405. Epub 2017 Jan 11.

25.

Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor-Mediated Signaling in Human Amnion and Myometrium.

Kim SH, Pohl O, Chollet A, Gotteland JP, Fairhurst AD, Bennett PR, Terzidou V.

Mol Pharmacol. 2017 Apr;91(4):403-415. doi: 10.1124/mol.116.106013. Epub 2017 Feb 10.

26.

Advances in the role of oxytocin receptors in human parturition.

Kim SH, Bennett PR, Terzidou V.

Mol Cell Endocrinol. 2017 Jul 5;449:56-63. doi: 10.1016/j.mce.2017.01.034. Epub 2017 Jan 22. Review.

27.

The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk.

Kindinger LM, Bennett PR, Lee YS, Marchesi JR, Smith A, Cacciatore S, Holmes E, Nicholson JK, Teoh TG, MacIntyre DA.

Microbiome. 2017 Jan 19;5(1):6. doi: 10.1186/s40168-016-0223-9.

28.

KODAMA: an R package for knowledge discovery and data mining.

Cacciatore S, Tenori L, Luchinat C, Bennett PR, MacIntyre DA.

Bioinformatics. 2017 Feb 15;33(4):621-623. doi: 10.1093/bioinformatics/btw705.

29.

Preterm Birth Prevention Post-Conization: A Model of Cervical Length Screening with Targeted Cerclage.

Kindinger LM, Kyrgiou M, MacIntyre DA, Cacciatore S, Yulia A, Cook J, Terzidou V, Teoh TG, Bennett PR.

PLoS One. 2016 Nov 3;11(11):e0163793. doi: 10.1371/journal.pone.0163793. eCollection 2016.

30.

The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?

Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M.

Microbiome. 2016 Nov 1;4(1):58. Review.

31.

The Local and Systemic Immune Response to Intrauterine LPS in the Prepartum Mouse.

Edey LF, O'Dea KP, Herbert BR, Hua R, Waddington SN, MacIntyre DA, Bennett PR, Takata M, Johnson MR.

Biol Reprod. 2016 Dec;95(6):125. Epub 2016 Oct 19.

32.

The Risk of Adverse Pregnancy Outcomes Following Nonobstetric Surgery During Pregnancy: Estimates From a Retrospective Cohort Study of 6.5 Million Pregnancies.

Balinskaite V, Bottle A, Sodhi V, Rivers A, Bennett PR, Brett SJ, Aylin P.

Ann Surg. 2017 Aug;266(2):260-266. doi: 10.1097/SLA.0000000000001976.

33.

Relationship between vaginal microbial dysbiosis, inflammation, and pregnancy outcomes in cervical cerclage.

Kindinger LM, MacIntyre DA, Lee YS, Marchesi JR, Smith A, McDonald JA, Terzidou V, Cook JR, Lees C, Israfil-Bayli F, Faiza Y, Toozs-Hobson P, Slack M, Cacciatore S, Holmes E, Nicholson JK, Teoh TG, Bennett PR.

Sci Transl Med. 2016 Aug 3;8(350):350ra102. doi: 10.1126/scitranslmed.aag1026.

34.

Obstetric complications after treatment of cervical intraepithelial neoplasia.

Mitra A, Kindinger L, Kalliala I, Smith JR, Paraskevaidis E, Bennett PR, Kyrgiou M.

Br J Hosp Med (Lond). 2016 Aug 2;77(8):C124-7. doi: 10.12968/hmed.2016.77.8.C124. Review. No abstract available.

35.

Modeling hormonal and inflammatory contributions to preterm and term labor using uterine temporal transcriptomics.

Migale R, MacIntyre DA, Cacciatore S, Lee YS, Hagberg H, Herbert BR, Johnson MR, Peebles D, Waddington SN, Bennett PR.

BMC Med. 2016 Jun 13;14(1):86. doi: 10.1186/s12916-016-0632-4.

36.

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.

Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, Robson SC, McConnachie A, Petrou S, Sebire NJ, Lavender T, Whyte S, Norrie J; OPPTIMUM study group.

Lancet. 2016 May 21;387(10033):2106-2116. doi: 10.1016/S0140-6736(16)00350-0. Epub 2016 Feb 24. Erratum in: Lancet. 2019 Jan 19;393(10168):228. Lancet. 2019 Apr 20;393(10181):1596.

37.

The oxytocin receptor antagonist, Atosiban, activates pro-inflammatory pathways in human amnion via G(αi) signalling.

Kim SH, MacIntyre DA, Hanyaloglu AC, Blanks AM, Thornton S, Bennett PR, Terzidou V.

Mol Cell Endocrinol. 2016 Jan 15;420:11-23. doi: 10.1016/j.mce.2015.11.012. Epub 2015 Nov 14.

38.

Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity.

Mitra A, MacIntyre DA, Lee YS, Smith A, Marchesi JR, Lehne B, Bhatia R, Lyons D, Paraskevaidis E, Li JV, Holmes E, Nicholson JK, Bennett PR, Kyrgiou M.

Sci Rep. 2015 Nov 17;5:16865. doi: 10.1038/srep16865.

39.

Sulfasalazine augments a pro-inflammatory response in interleukin-1β-stimulated amniocytes and myocytes.

Sykes L, Thomson KR, Boyce EJ, Lee YS, Rasheed ZB, MacIntyre DA, Teoh TG, Bennett PR.

Immunology. 2015 Dec;146(4):630-44. doi: 10.1111/imm.12534. Epub 2015 Nov 3.

40.

Progesterone and the Repression of Myometrial Inflammation: The Roles of MKP-1 and the AP-1 System.

Lei K, Georgiou EX, Chen L, Yulia A, Sooranna SR, Brosens JJ, Bennett PR, Johnson MR.

Mol Endocrinol. 2015 Oct;29(10):1454-67. doi: 10.1210/me.2015-1122. Epub 2015 Aug 17.

41.

Specific Lipopolysaccharide Serotypes Induce Differential Maternal and Neonatal Inflammatory Responses in a Murine Model of Preterm Labor.

Migale R, Herbert BR, Lee YS, Sykes L, Waddington SN, Peebles D, Hagberg H, Johnson MR, Bennett PR, MacIntyre DA.

Am J Pathol. 2015 Sep;185(9):2390-401. doi: 10.1016/j.ajpath.2015.05.015. Epub 2015 Jul 26.

42.

Specific inhibition of c-Jun N-terminal kinase delays preterm labour and reduces mortality.

Pirianov G, MacIntyre DA, Lee Y, Waddington SN, Terzidou V, Mehmet H, Bennett PR.

Reproduction. 2015 Oct;150(4):269-77. doi: 10.1530/REP-15-0258. Epub 2015 Jul 16.

43.

Quantitative fetal fibronectin to predict preterm birth in asymptomatic women at high risk.

Abbott DS, Hezelgrave NL, Seed PT, Norman JE, David AL, Bennett PR, Girling JC, Chandirimani M, Stock SJ, Carter J, Cate R, Kurtzman J, Tribe RM, Shennan AH.

Obstet Gynecol. 2015 May;125(5):1168-76. doi: 10.1097/AOG.0000000000000754.

PMID:
25932845
44.

The vaginal microbiome during pregnancy and the postpartum period in a European population.

MacIntyre DA, Chandiramani M, Lee YS, Kindinger L, Smith A, Angelopoulos N, Lehne B, Arulkumaran S, Brown R, Teoh TG, Holmes E, Nicoholson JK, Marchesi JR, Bennett PR.

Sci Rep. 2015 Mar 11;5:8988. doi: 10.1038/srep08988.

45.

Exogenous oxytocin modulates human myometrial microRNAs.

Cook JR, MacIntyre DA, Samara E, Kim SH, Singh N, Johnson MR, Bennett PR, Terzidou V.

Am J Obstet Gynecol. 2015 Jul;213(1):65.e1-65.e9. doi: 10.1016/j.ajog.2015.03.015. Epub 2015 Mar 7.

46.

Oxytocin activates NF-κB-mediated inflammatory pathways in human gestational tissues.

Kim SH, MacIntyre DA, Firmino Da Silva M, Blanks AM, Lee YS, Thornton S, Bennett PR, Terzidou V.

Mol Cell Endocrinol. 2015 Mar 5;403:64-77. doi: 10.1016/j.mce.2014.11.008. Epub 2014 Nov 14.

47.

Anti-inflammatory prostaglandins for the prevention of preterm labour.

Sykes L, MacIntyre DA, Teoh TG, Bennett PR.

Reproduction. 2014 Aug;148(2):R29-40. doi: 10.1530/REP-13-0587. Epub 2014 Jun 2. Review.

PMID:
24890751
48.

Activator protein 1 is a key terminal mediator of inflammation-induced preterm labor in mice.

MacIntyre DA, Lee YS, Migale R, Herbert BR, Waddington SN, Peebles D, Hagberg H, Johnson MR, Bennett PR.

FASEB J. 2014 May;28(5):2358-68. doi: 10.1096/fj.13-247783. Epub 2014 Feb 4.

PMID:
24497579
49.

Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.

Cartwright R, Mangera A, Tikkinen KA, Rajan P, Pesonen J, Kirby AC, Thiagamoorthy G, Ambrose C, Gonzalez-Maffe J, Bennett PR, Palmer T, Walley A, Järvelin MR, Khullar V, Chapple C.

Eur Urol. 2014 Oct;66(4):752-68. doi: 10.1016/j.eururo.2014.01.007. Epub 2014 Jan 22. Review.

50.

EP2 receptor activates dual G protein signaling pathways that mediate contrasting proinflammatory and relaxatory responses in term pregnant human myometrium.

Kandola MK, Sykes L, Lee YS, Johnson MR, Hanyaloglu AC, Bennett PR.

Endocrinology. 2014 Feb;155(2):605-17. doi: 10.1210/en.2013-1761. Epub 2013 Nov 21.

PMID:
24265450

Supplemental Content

Loading ...
Support Center